Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
19 Jul 2024 |
CS01 |
Confirmation statement made on 19 July 2024 with updates
|
|
|
19 Jul 2024 |
CH01 |
Director's details changed for Annie Ong on 18 July 2024
|
|
|
19 Mar 2024 |
AP01 |
Appointment of Guy Edward Oliver as a director on 11 March 2024
|
|
|
18 Dec 2023 |
AA |
Full accounts made up to 30 June 2023
|
|
|
17 Nov 2023 |
TM01 |
Termination of appointment of John Scott Cooke as a director on 8 November 2023
|
|
|
17 Nov 2023 |
AP01 |
Appointment of Annie Ong as a director on 8 November 2023
|
|
|
16 Oct 2023 |
SH01 |
Statement of capital following an allotment of shares on 6 October 2023
|
|
|
25 Jul 2023 |
CS01 |
Confirmation statement made on 19 July 2023 with no updates
|
|
|
06 Jul 2023 |
CH01 |
Director's details changed for Director Kimberly Mccutcheon Jablonski on 1 July 2023
|
|
|
03 Jul 2023 |
PSC05 |
Change of details for Bristol-Myers Squibb Company as a person with significant control on 1 July 2023
|
|
|
27 Mar 2023 |
AA |
Full accounts made up to 30 June 2022
|
|
|
03 Oct 2022 |
TM01 |
Termination of appointment of Teresa Maria Vargas Quintas Campos as a director on 3 October 2022
|
|
|
19 Jul 2022 |
CS01 |
Confirmation statement made on 19 July 2022 with no updates
|
|
|
10 Feb 2022 |
AP01 |
Appointment of Director Kimberly Mccutcheon Jablonski as a director on 19 January 2022
|
|
|
09 Feb 2022 |
TM01 |
Termination of appointment of David Walter Pignolet as a director on 19 January 2022
|
|
|
09 Feb 2022 |
TM01 |
Termination of appointment of Katherine Reynolds Kelly as a director on 17 September 2021
|
|
|
05 Jan 2022 |
AA |
Full accounts made up to 30 June 2021
|
|
|
10 Aug 2021 |
AP01 |
Appointment of John Scott Cooke as a director on 20 July 2021
|
|
|
31 Jul 2021 |
CS01 |
Confirmation statement made on 20 July 2021 with no updates
|
|
|
26 Jul 2021 |
TM01 |
Termination of appointment of Lynelle B. Hoch as a director on 20 July 2021
|
|
|
15 Jun 2021 |
AA |
Full accounts made up to 30 June 2020
|
|
|
02 Aug 2020 |
CS01 |
Confirmation statement made on 20 July 2020 with no updates
|
|
|
15 May 2020 |
PSC02 |
Notification of Bristol-Myers Squibb Company as a person with significant control on 20 November 2019
|
|
|
15 May 2020 |
PSC07 |
Cessation of Celgene Corporation as a person with significant control on 20 November 2019
|
|
|
13 May 2020 |
AP01 |
Appointment of Katherine Reynolds Kelly as a director on 30 April 2020
|
|